EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY 4.0

IL-31/33 Axis in Atopic Dermatitis

Julia Łacwik iD, Krzysztof Kraik iD, Julia Laska, Maciej Tota iD, Łukasz Sędek iD, Krzysztof Gomułka iD

International Journal of Molecular Sciences · 2025

DOI: 10.3390/ijms262010162 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift International Journal of Molecular Sciences, 2025. Verfasst von Julia Łacwik und 5 weiteren Autor:innen. Beteiligte Einrichtung: Student Research Group of Microbiology and Immunology, Department of Microbiology and Immunology in Zabrze, Medical University of Silesia in Katowice…. Hauptthemen laut MEDLINE: Dermatitis, Atopic, Interleukin-33, Interleukins. Die Arbeit wurde bisher 14-mal zitiert (Crossref) und nennt 126 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Atopic dermatitis (AD) is a chronic inflammatory skin disorder characterized by impaired epidermal barrier function, immune dysregulation (e.g., Th2 polarization), genetic factors (e.g., filaggrin mutations), environmental triggers and microbial dysbiosis, leading to pruritus and eczematous lesions. In this review, we present the synergistic “IL-31/IL-33 axis.” IL-33, released by damaged keratinocytes, acts as an alarmin, initiating inflammation via ST2 receptors and promoting Th2 cytokine production (IL-4, IL-5, IL-13). This upregulates IL-31, primarily from Th2 cells, which directly activates sensory neurons to induce pruritus and impairs keratinocyte differentiation. Together, IL-31 and IL-33 exacerbate the itch–scratch feedback loop, barrier disruption, and inflammation. Elevated levels of IL-31 and IL-33 correlate with disease severity. Targeting the IL-31/IL-33 axis represents an emerging therapeutic option, e.g., nemolizumab (anti-IL-31RA) significantly reduces pruritus and AD symptoms in clinical trials. However, anti-IL-33/ST2 agents (e.g., etokimab, tozorakimab) demonstrate variable efficacy, highlighting complexity in targeting IL-33. Future research should prioritize biomarker-driven patient stratification to optimize the clinical application of these novel antibody-based therapies.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Dermatitis, AtopicInterleukin-33InterleukinsHumansFilaggrin ProteinsAnimalsPruritusInterleukin-1 Receptor-Like 1 ProteinSignal TransductionKeratinocytesTh2 Cells

Stichwörter der Autor:innen

ADIL-31IL-31/IL-33 axisIL-33atopic dermatitisbiologicaltherapy

Substanzen

Interleukin-33IL31 protein, humanFilaggrin ProteinsInterleukinsIL33 protein, humanFLG protein, humanInterleukin-1 Receptor-Like 1 ProteinIL1RL1 protein, human

Autor:innen und Institutionen

  • Student Research Group of Microbiology and Immunology, Department of Microbiology and Immunology in Zabrze, Medical University of Silesia in Katowice, 40-055 Katowice, Poland.
  • Student Research Group of Allergology and Internal Medicine, Clinical Department of Allergology and Internal Medicine, Wroclaw Medical University, 50-556 Wrocław, Poland.
  • Department of Microbiology and Immunology in Zabrze, Medical University of Silesia in Katowice, 40-055 Katowice, Poland.
  • Clinical Department of Allergology and Internal Medicine, Wroclaw Medical University, 50-556 Wrocław, Poland.

ORCID-Profile: Julia Łacwik, Krzysztof Kraik, Maciej Tota, Łukasz Sędek, Krzysztof Gomułka

Zitieren

APA

Łacwik, J., Kraik, K., Laska, J., Tota, M., Sędek, Ł., & Gomułka, K. (2025). IL-31/33 Axis in Atopic Dermatitis. International Journal of Molecular Sciences. https://doi.org/10.3390/ijms262010162

Vancouver

Łacwik J, Kraik K, Laska J, Tota M, Sędek Ł, Gomułka K. IL-31/33 Axis in Atopic Dermatitis. International Journal of Molecular Sciences. 2025. doi:10.3390/ijms262010162

BibTeX
@article{acwik2025,
  author = {Łacwik, Julia and Kraik, Krzysztof and Laska, Julia and Tota, Maciej and Sędek, Łukasz and Gomułka, Krzysztof},
  title = {IL-31/33 Axis in Atopic Dermatitis},
  journal = {International Journal of Molecular Sciences},
  year = {2025},
  doi = {10.3390/ijms262010162}
}
Kostenlos starten →